Fujian Wanchen Biotechnology Group Past Earnings Performance
Past criteria checks 2/6
Fujian Wanchen Biotechnology Group's earnings have been declining at an average annual rate of -46.2%, while the Food industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 82.4% per year. Fujian Wanchen Biotechnology Group's return on equity is 28.1%, and it has net margins of 0.2%.
Key information
-46.2%
Earnings growth rate
-50.2%
EPS growth rate
| Food Industry Growth | 7.2% |
| Revenue growth rate | 82.4% |
| Return on equity | 28.1% |
| Net Margin | 0.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality
Nov 04
Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company
Oct 01Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing
Sep 30We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt
Aug 04Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)
Jun 06Revenue & Expenses Breakdown
How Fujian Wanchen Biotechnology Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 25,006 | 58 | 1,889 | 4 |
| 30 Jun 24 | 17,992 | -76 | 1,481 | 4 |
| 31 Mar 24 | 13,362 | -129 | 1,158 | 4 |
| 31 Dec 23 | 9,294 | -83 | 876 | 3 |
| 30 Sep 23 | 5,091 | -46 | 536 | 3 |
| 30 Jun 23 | 2,564 | 40 | 277 | 2 |
| 31 Mar 23 | 1,194 | 76 | 112 | 2 |
| 01 Jan 23 | 549 | 48 | 52 | 2 |
| 30 Sep 22 | 546 | 82 | 29 | 1 |
| 30 Jun 22 | 471 | 38 | 25 | 2 |
| 31 Mar 22 | 448 | 25 | 26 | 2 |
| 01 Jan 22 | 435 | 23 | 25 | 2 |
| 30 Sep 21 | 371 | 4 | 25 | 2 |
| 30 Jun 21 | 399 | 33 | 24 | 0 |
| 31 Mar 21 | 417 | 65 | 22 | 0 |
| 31 Dec 20 | 450 | 96 | 22 | 0 |
| 30 Sep 20 | 449 | 101 | 23 | 0 |
| 30 Jun 20 | 460 | 110 | 24 | 0 |
| 31 Mar 20 | 483 | 130 | 24 | 0 |
| 31 Dec 19 | 451 | 92 | 24 | 0 |
| 30 Sep 19 | 442 | 82 | 40 | 0 |
| 30 Jun 19 | 418 | 74 | 24 | 0 |
| 31 Mar 19 | 358 | 28 | 28 | 0 |
| 01 Jan 19 | 343 | 35 | 23 | 0 |
| 30 Sep 18 | 298 | 15 | 18 | 0 |
| 30 Jun 18 | 258 | -3 | 19 | 0 |
| 31 Mar 18 | 265 | 24 | 18 | 0 |
| 01 Jan 18 | 247 | 16 | 18 | 0 |
| 30 Sep 17 | 259 | 31 | 5 | 0 |
| 30 Jun 17 | 267 | 46 | 16 | 0 |
| 31 Mar 17 | 254 | 52 | 11 | 0 |
| 31 Dec 16 | 220 | 39 | 14 | 0 |
| 30 Sep 16 | 189 | 40 | 14 | 0 |
| 30 Jun 16 | 157 | 30 | 14 | 0 |
| 31 Mar 16 | 157 | 31 | 14 | 0 |
| 31 Dec 15 | 157 | 33 | 14 | 0 |
| 30 Sep 15 | 149 | 30 | 11 | 0 |
| 30 Jun 15 | 160 | 37 | 12 | 0 |
| 31 Mar 15 | 145 | 35 | 11 | 0 |
| 31 Dec 14 | 130 | 34 | 11 | 0 |
Quality Earnings: 300972 has high quality earnings.
Growing Profit Margin: 300972 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300972's earnings have declined by 46.2% per year over the past 5 years.
Accelerating Growth: 300972 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 300972 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Food industry (-5.8%).
Return on Equity
High ROE: Whilst 300972's Return on Equity (28.14%) is high, this metric is skewed due to their high level of debt.